Plant Strategies, Vegetation Processes, and Ecosystem Properties, Second Edition, is a thoroughly updated and comprehensive new edition of the very successful Plant Strategies and Vegetative Processes, which controversially proposed the existence of widely-recurring plant functional types with predictable relationships to vegetation structure and dynamics. This second edition uses evidence from many parts of the world to re-examine these concepts in the light of the enormous expansion in the literature. Features include: * A new section covering all aspects of ecosystem properties * New chapters on Assembling of Communities Rarification and Extinction Colonisation and Invasion * Principles and methodologies of a range of international tests including case study examples * Chapter summaries for a quick reference guide * Index of species names Written in a very readable style, this book is an invaluable reference source for researchers in the areas of plant, animal, and community ecology, conservation and land management. 'Written by one of the foremost authorities in the field, summarising over 35 years of research. A book all plant ecologists will want to read.' - Jonathan Silvertown, Department of Biological Sciences, The Open University, UK. 'The coverage is outstanding and comprehensive.' - Simon A. Levin, Department of Ecology and Evolutionary Biology, Princeton University, USA
Therapeutic risk management of medicines is an authoritative and practical guide on developing, implementing and evaluating risk management plans for medicines globally. It explains how to assess risks and benefit-risk balance, design and roll out risk minimisation and pharmacovigilance activities, and interact effectively with key stakeholders.A more systematic approach for managing the risks of medicines arose following a number of high-profile drug safety incidents and a need for better access to effective but potentially risky treatments. Regulatory requirements have evolved rapidly over the past decade. Risk management plans (RMPs) are mandatory for new medicinal products in the EU and a Risk Evaluation and Mitigation Strategy (REMS) is needed for certain drugs in the US.This book is an easy-to-read resource that complements current regulatory guidance, by exploring key areas and practical implications in greater detail. It is structured into chapters encompassing a background to therapeutic risk management, strategies for developing RMPs, implementation of RMPs, and the continuing evolution of the risk management field.The topic is of critical importance not only to the pharmaceutical and biotechnology industries, but also regulators and healthcare policymakers.Some chapters feature contributions from selected industry experts. - An up-to-date practical guide on conceiving, designing, and implementing global therapeutic risk management plans for medicines - A number of useful frameworks are presented which add impact to RMPs (Risk Management Plans), together with regional specific information (European Union, United States, and Japan) - A comprehensive guide for performing risk management more effectively throughout a product's life-cycle
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.